Application
Fig1: Western blot analysis of Aurora A on human Aurora A recombinant protein using anti- Aurora A antibody at 1/1,000 dilution.
Application
Fig2: Western blot analysis of Aurora A on HEK293 (1) and Aurora A -hIgGFc transfected HEK293 (2) cell lysate using anti- Aurora A antibody at 1/1,000 dilution.
Application
Fig3: Western blot analysis of Aurora A on different cell lysate using anti- Aurora A antibody at 1/1,000 dilution. Positive control: Line1: HEK293 Line2: MCF-7 Line3: Hela
Application
Fig4: ICC staining Aurora A (green) and Actin filaments (red) in Hela cells. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
Application
Fig5: ICC staining Aurora A (green) and Actin filaments (red) in SMMC-7721 cells. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
Application
Fig6: Immunohistochemical analysis of paraffin-embedded human cervical cancer tissue using anti- Aurora A antibody. Counter stained with hematoxylin.
Application
Fig7: Immunohistochemical analysis of paraffin-embedded human rectum cancer tissue using anti- Aurora A antibody. Counter stained with hematoxylin.
Application
Fig8: Flow cytometric analysis of Hela cells with Aurora A antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; red).